Tenofovir alafenamide hemifumarate intermediate 99% 379270-37-8
TDS 1 Inquiries
379270-37-8
Pharmaceutical Grade
99%
Xinke
foil bag
Yes
2022-02-15
Tenofovir alafenamide intermediate,Axitinib,Avatrombopag intermediate,Tenofovir alafenamide hemifumarate,Axitinib intermediate,Lenvatinib intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceTenofovir alafenamide (GS-7340) is an investigational oral prodrug of Tenofovir. Tenofovir is a HIV-1 nucleotide reverse transcriptase inhibitor.CertificatesBasic Info
-
Product Name:
Tenofovir alafenamide
Other Name:L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-,1-methylethyl ester;GS 7340;Tenofovir alafenamide;4: PN: WO2016077321 SEQID: 4 claimed sequence;Vemlidy;377091-31-1
CAS No.:379270-37-8
Molecular Formula:C21H29N6O5P
InChIKeys:InChIKey=LDEKQSIMHVQZJK-CAQYMETFSA-N
Molecular Weight:476.466
Exact Mass:476.47
Categories:
Characteristics-
PSA:
153.29000
XLogP3:1.9
Density:1.39±0.1 g/cm3
Melting Point:104-107 ºC
Boiling Point:640.4±65.0 °C at 760 mmHg
Flash Point:341.1±34.3 °C
Refractive Index:1.630
Water Solubility:4.86 mg/ml at 20 ºC
PKA:3.96None
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tenofovir alafenamide intermediate,Axitinib,Avatrombopag intermediate,Tenofovir alafenamide hemifumarate,Axitinib intermediate,Lenvatinib intermediate
-
Location:
No.108-102,Xinmao Qilu Science city,, Tianqiao district, Jinan City,
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
300 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2015
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Bangladesh
Tenofovir Alafenamide
1 KG Jan 5, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Lenvatinib free base 417716-92-8
Pharmaceutical Grade / 99%
-
-
-
-
Tenofovir alafenamide hemifumarate 99% 1392275-56-7 Xinke
Pharmaceutical Grade / 99%
-
-
-
-
Axitinib 99% white to tan 319460-85-0
Pharmaceutical Grade / 99%
-
-
-
-
Lenvatinib Intermediate 17609-80-2
Pharmaceutical Grade / 98%
-
-
-
-
Axitinib intermediate 886230-75-7
Pharmaceutical Grade / 99%
-
-
-
-
Lenvatinib Mesylate 99% 857890-39-2
Pharmaceutical Grade / 99%
-
